Page last updated: 2024-11-05

trientine and Anemia, Sideroblastic

trientine has been researched along with Anemia, Sideroblastic in 2 studies

Trientine: An ethylenediamine derivative used as stabilizer for EPOXY RESINS, as ampholyte for ISOELECTRIC FOCUSING and as chelating agent for copper in HEPATOLENTICULAR DEGENERATION.
TETA : An azamacrocyle in which four nitrogen atoms at positions 1, 4, 8 and 11 of a fouteen-membered ring are each substituted with a carboxymethyl group.
2,2,2-tetramine : A polyazaalkane that is decane in which the carbon atoms at positions 1, 4, 7 and 10 are replaced by nitrogens.

Anemia, Sideroblastic: Anemia characterized by the presence of erythroblasts containing excessive deposits of iron in the marrow.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Condamine, L1
Hermine, O1
Alvin, P1
Levine, M1
Rey, C1
Courtecuisse, V1
Perry, AR1
Pagliuca, A1
Fitzsimons, EJ1
Mufti, GJ1
Williams, R1

Other Studies

2 other studies available for trientine and Anemia, Sideroblastic

ArticleYear
Acquired sideroblastic anaemia during treatment of Wilson's disease with triethylene tetramine dihydrochloride.
    British journal of haematology, 1993, Volume: 83, Issue:1

    Topics: Adolescent; Anemia, Sideroblastic; Female; Hepatolenticular Degeneration; Humans; Trientine

1993
Acquired sideroblastic anaemia induced by a copper-chelating agent.
    International journal of hematology, 1996, Volume: 64, Issue:1

    Topics: Adolescent; Anemia, Sideroblastic; Chelating Agents; Copper; Female; Hepatolenticular Degeneration;

1996